Editorial: Cancer immunotherapy: does an increasing arsenal of tools point to more fruitful avenues for research?
Bo
B
Jin
Consultant Highland Park, New Jersey USA. anthony.yeo@uni.sydney.edu.au.
Anthony E T
AE
Yeo
D000970:Antineoplastic Agents / Q000276:immunology / Q000627:therapeutic use; D035843:Biomedical Research; D019496:Cancer Vaccines / Q000627:therapeutic use; D003602:Cytotoxicity, Immunologic; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D009369:Neoplasms / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D012107:Research Design
D000970:Antineoplastic Agents; D019496:Cancer Vaccines; D047428:Protein Kinase Inhibitors